Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors
| Autor: | François Harel, Heidi Patriquin, Nathalie J. Bureau, Claude C. Roy, C. Lenaerts, Jacques E. Marcotte, Chantale Lapierre, Guy Lepage |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Liver Cirrhosis
Male medicine.medical_specialty Cirrhosis Time Factors Adolescent Cystic Fibrosis Gastroenterology Cystic fibrosis Severity of Illness Index Cohort Studies Liver disease Predictive Value of Tests Risk Factors Internal medicine Hypertension Portal medicine Humans Risk factor Child Ultrasonography Univariate analysis business.industry Hepatobiliary disease medicine.disease Surgery Distal intestinal obstruction syndrome Child Preschool Population Surveillance Pediatrics Perinatology and Child Health Female medicine.symptom business Cohort study Follow-Up Studies |
| Zdroj: | The Journal of pediatrics. 143(3) |
| ISSN: | 0022-3476 |
| Popis: | Objective To investigate routine ultrasonography (US) as an early marker and to identify risk factors for the development of cirrhosis and portal hypertension (PHT) in cystic fibrosis (CF). Study design A cohort of 106 children with CF aged 5.9±2.3 years were followed for 10.4±0.2 years in a CF clinic. Results At enrollment, the US was normal, but biochemical and/or clinical disease was present in 10%. By the end of the study, 19 had developed US changes, eight with evidence of PHT. At the time of the initial US change, only 36.4% of those had, at the end of the study, either a heterogeneous or a nodular parenchyma, and only 50% of those with PHT had biochemical and/or clinical disease. Of the 30 patients treated with ursodeoxycholic acid for biochemical and/or clinical disease with (n = 15) and without (n = 15) associated US changes, PHT developed in six of the former and two of the latter. Univariate analysis and logistic regression showed that children with more severe disease in terms of forced expiratory volume in one second were at somewhat greater risk ( P Conclusion US was an early marker of liver disease and more severe CF disease, a predictor of progressive liver disease. A controlled trial should be done to assess isolated US-detected disease as an indication for UDCA. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect